U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Chatham Capital Group Inc.

Chatham Capital Group Inc. lessened its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,940 shares of the company’s stock after selling 770 shares during the quarter. Chatham Capital Group Inc.’s holdings in U.S. Physical Therapy were worth $1,680,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Venturi Wealth Management LLC increased its holdings in shares of U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares during the last quarter. KBC Group NV increased its holdings in shares of U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after purchasing an additional 315 shares during the last quarter. Pacer Advisors Inc. acquired a new stake in U.S. Physical Therapy during the fourth quarter worth $113,000. First Horizon Advisors Inc. increased its stake in U.S. Physical Therapy by 25.1% during the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock worth $126,000 after acquiring an additional 298 shares during the last quarter. Finally, International Assets Investment Management LLC increased its stake in U.S. Physical Therapy by 8,414.8% during the third quarter. International Assets Investment Management LLC now owns 2,299 shares of the company’s stock worth $195,000 after acquiring an additional 2,272 shares during the last quarter.

Analysts Set New Price Targets

Several research firms have issued reports on USPH. JMP Securities began coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their target price for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. Barrington Research cut their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. JPMorgan Chase & Co. raised their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Finally, William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $111.50.

U.S. Physical Therapy Stock Up 2.2 %

USPH opened at $83.06 on Friday. The business’s 50-day simple moving average is $87.60 and its 200-day simple moving average is $87.54. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63. The stock has a market capitalization of $1.25 billion, a P/E ratio of 88.36, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. Analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.17%. The ex-dividend date is Friday, March 14th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is 97.83%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares in the company, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.70% of the stock is currently owned by insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.